DoW Autism Clinical Trial Award
DoW Autism Clinical Trial Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 22 Oct 2026. Summary: The fiscal year 2026 (FY26) Autism Research Program (ARP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of autism. Clinical trials may be designed to evaluate promising new products, p…
Opportunity overview
- Project name
- DoW Autism Clinical Trial Award
- Donor
- Defense Health Agency Contracting Activity - DHACA
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is DoW Autism Clinical Trial Award?
DoW Autism Clinical Trial Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 22 Oct 2026. Summary: The fiscal year 2026 (FY26) Autism Research Program (ARP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of autism. Clinical trials may be designed to evaluate promising new products, p…
Who is funding DoW Autism Clinical Trial Award?
DoW Autism Clinical Trial Award is funded by Defense Health Agency Contracting Activity - DHACA.
When is the deadline to apply for DoW Autism Clinical Trial Award?
The application deadline is 22 Oct 2026 00:00 (UTC).
Where will the DoW Autism Clinical Trial Award project take place?
The project location(s) are: United States.
How can I apply for DoW Autism Clinical Trial Award?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.